Ziconotide Combination Intrathecal Therapy for Noncancer Pain Is Limited Secondary to Delayed Adverse Effects: A Case Series With a 24-Month Follow-Up.

Hayek, Salim M

Ziconotide Combination Intrathecal Therapy for Noncancer Pain Is Limited Secondary to Delayed Adverse Effects: A Case Series With a 24-Month Follow-Up. [electronic resource] - Neuromodulation : journal of the International Neuromodulation Society Jul 2015 - 397-403 p. digital

Publication Type: Journal Article

1525-1403

10.1111/ner.12270 doi


Analgesics, Non-Narcotic--adverse effects
Cohort Studies
Combined Modality Therapy
Female
Humans
Injections, Spinal--adverse effects
Male
Middle Aged
Pain--drug therapy
Pain Management
Pain Measurement
omega-Conotoxins--adverse effects